Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADA: Vitamin D and Phototherapy in Atopic Dermatitis
NCT02537509Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Oct 2015
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Cholecalciferol with Placebo (2 arms). Primary endpoints: Patient-Oriented SCORing Atopic Dermatitis at 2 years and Cumulative Consumption of Topical Anti-inflammatory Treatments at 2 years. Started Oct 2015; status: completed.
02
Drugs
vitamin d
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02537509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537509.